NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related WoundsLANGHORNE, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that it has launched a new product dubbed Turfguard, a unique hydrogel dressing for soothing turf burn and protecting athletic wounds. Turfguard’s sterile silver patches, cleared by the U.S. Food and Drug Administration, kill 99 percent of staph, MRSA and strep.
NEXGEL Reports Third Quarter 2022 Financial ResultsRevenue increased 69.6% YoY while gross profit margin improved both sequentially and YoY to 26%
NEXGEL to Report Third Quarter 2022 Financial Results on November 8thManagement will host a conference call at 4:30 P.M. ET on the same day
NEXGEL Reports Positive Results from Proof-of-Concept Study for its Diclofenac Hydrogel Pain TreatmentLANGHORNE, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today positive results from its proof-of-concept study for its diclofenac hydrogel patches. The patches are designed to treat pain indications such as arthritis, joint pain, muscle aches and more.
NEXGEL Develops New Hydrogel Patch to Treat AmblyopiaPatch Will Be Available to Ophthalmologists and Optometrists in 1H 2023
NEXGEL to Participate in Upcoming Investor Conferences in October 2022LANGHORNE, Pa., Oct. 04, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced that Adam Levy, CEO, will participate at the Dawson James Securities 7th Annual Small Cap Growth Conference in Jupiter, Florida and the LD Micro Main Event XV Conference in Los Angeles, California in October 2022.
SAGE Journals Publishes New Data Revealing NEXGEL’s SilverSeal Hydrogel Dressing Improves Postsurgical Scarring Patients Treated with SilverSeal Experienced Significantly Less Scarring and Improved Skin Functionality Following Surgical Incision
NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory BoardLANGHORNE, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that the Company has appointed Dr. Neil Chesen and Dr. Leonard Nelson to its Scientific Advisory Board.
